Skip to main content
. Author manuscript; available in PMC: 2013 Feb 22.
Published in final edited form as: Am J Psychiatry. 2007 Sep;164(9):1340–1347. doi: 10.1176/appi.ajp.2007.07020311

TABLE 1.

Demographic and Illness History Attributes of the Study Samplea

Variable Total Study Sample (N=152)
N %

Sex (female) 88 59
Race (nonwhite) 8 5
Education (>1 year of college) 83 56
Income (<$29,999) 61 45
Marital status
 Married 47 31
 Unmarried 56 37
 Separated 48 32
Family availability (yes) 80 53
Diagnosis
 Bipolar I disorder 105 69
 Bipolar II disorder 47 31
Prior manic episodes (>10) 104 68
Prior depressive episodes (>10) 103 69
Rapid cycling prior year (yes) 42 30
Receiving medication (yes)
 Mood stabilizers 130 96
 Antidepressants 43 32
 Carbamazepine 7 5
 Lithium 72 53
 Lamotrigine 37 27
 Divalproex sodium 46 34
 Atypical antipsychotics 41 30
  Olanzapine/Quetiapine 29 19
 Anxiolytics 27 20

Mean SD

Age (years) 41.09 11.37
Age at illness onset (years) 15.68 8.02
Baseline Montgomery-Åsberg Depression Rating Scale scoreb 21.50 9.97
Baseline Young Mania Rating Scale scoreb 5.45 5.82
Depression summary scorec 7.52 1.94
Mania summary scorec 1.04 0.90
Baseline Global Assessment of Functioning score 51.79 7.68
Duration of index major depressive episode (days) 220.02 828.07
a

Baseline medication regimens were unavailable on 17 patients.

b

Refers to scores collected at intake into the study.

c

Refers to summary scores from the Clinical Monitoring Form (10) collected within 1 week of the date of randomization to psychosocial interventions.